Brief: Sakar Healthcare Starting Liquid & Lyophilised Injection Unit
03/01/2023 08:49
Jan 3 (Reuters) - Sakar Healthcare Ltd SAKA.NS :
* STARTING LIQUID & LYOPHILISED INJECTION UNIT WITH TIE-UP
FOR
MANUFACTURING 5 KEY MOLECULES IN ONCOLOGY SEGMENT
* UNIT WILL HAVE INSTALLED MANUFACTURING CAPACITY OF OVER 15
MILLION VIALS ANNUALLY
* INJECTION UNIT IS ALL SET TO COMMERCIALIZE PRODUCTS FROM
APRIL
2023 ONWARDS
Source text for Eikon: ID:nNSE24gSL0
Further company coverage: SAKA.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sakar Healthcare
See all newsBrief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar
Brief: Sakar Healthcare Says Granted Two More Marketing Authorizations In EU
India's Sakar Healthcare rises on nod to market cancer injection in EU